Important Safety Information, including Boxed WARNING:

Approved Use

What is KYMRIAH? KYMRIAH is a prescription cancer treatment used in patients up to 25 years old who have acute lymphoblastic leukemia (ALL) that has relapsed (went into remission, then cam...

See More
What is the most important information I should know about KYMRIAH?

KYMRIAH may cause side effects that are severe or life-threatening, such as cytokine release syndrome (CRS) and neurological toxicities. Call your health care provider or get emergency help right away if you get any of...

See More
learn more about

Understanding KYMRIAH

KYMRIAH® (tisagenlecleucel) is a type of immunotherapy for patients with relapsed or refractory B-cell ALL. Discover how KYMRIAH works, what makes it different from other therapies, and whether it could be right for you.

learn more about

Where to Get Treatment

KYMRIAH is available at select treatment centers across the United States. Click below to find the locations nearest to you.